Percheron Therapeutics LimitedASX: PER

Positive preliminary results from ATL1102 DMD Phase II trial

Sep 18, 2019 at 5:06 AM UTC · Issued by Percheron Therapeutics Limited

Percheron Therapeutics Limited has released a press release.

View Attachment